Epithalon – 20mg

Description

Core Mechanisms of Action

Telomerase Activation: Epitalon’s signature mechanism is the induction of telomerase enzyme activity, which allows for the elongation of telomeres. In vitro studies on human fetal fibroblasts showed it could extend their proliferative potential beyond the Hayflick limit (from 34 to 44 passages).
Epigenetic Regulation: It binds to specific DNA sequences (particularly CAG sequences) and histones (H1/3 and H1/6), suggesting it acts as a gene-expression modulator to restore youthful protein synthesis patterns.
Neuroendocrine Support: It directly influences the pineal gland to stimulate melatonin synthesis. One human trial involving women found a 160% increase in melatonin synthesis compared to a placebo.
Antioxidant Defense: It strengthens intrinsic antioxidant defenses by boosting enzymes through Nrf2 activation, reducing oxidative damage markers in both brain and liver tissues.

Key Research Findings

Longevity Studies: In animal models (flies, mice, and rats), Epitalon has been shown to increase maximum lifespan by 11% to 16%. A long-term study on SHR mice found a 12.3% increase in maximum lifespan and a significant reduction in spontaneous tumor incidence.
Retinal Protection: Clinical trials in patients with retinitis pigmentosa reported positive clinical effects in 90% of cases, including improved visual fields and electrical activity in the retina.
Mortality Reduction: A 12-year prospective cohort study in elderly patients using Epithalamin (the natural extract) reported a 28% reduction in overall mortality and a 50% lower rate of cardiovascular-specific mortality.

Safety and Side Effects

Clinical Observations: Long-term clinical trials (up to 15 years) have reported that Epitalon is generally well-tolerated with no severe adverse events.
Common Reactions: Mild, transient side effects may include injection site reactions (redness or swelling), occasional digestive issues, or temporary fatigue.
Regulatory & Research Status: Although widely used in biohacking, it has not undergone large-scale, independent Phase I safety trials or formal toxicology studies. It is currently available primarily as a research chemical.